Ocata Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

OCAT 6.54 -0.10 (-1.51%)
price chart
Advanced Cell Technology Changes Name to Ocata Therapeutics
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc., (OTCBB: OCAT) today announced the change of its company name to Ocata Therapeutics, Inc., effective immediately. The change, which has been approved by the Company's ...
Related articles »  
Ocata Therapeutics To Trade On Nasdaq Global Market: Can The Bulls Finally ...
After months, if not years for some, Ocata shareholders were pleasantly surprised by the after-hours filing of the Form 8-A on February 23, 2015 by Ocata Therapeutics (NASDAQ:OCAT), which provides for registration of certain classes of securities ...
Ocata Therapeutics Approved for Listing on NASDAQ  Yahoo Finance UK
Ocata Therapeutics to Present at 2015 Cowen Health Care Conference  MarketWatch
The Butterfly Effect: Advanced Cell Technology Becomes Ocata Therapeutics ...
Ocata Therapeutics has entered an optimal moment in its developmental life cycle to initiate a long position. Prior to the as yet unknown date of up-list to the NASDAQ, which will occur with an accompanying equity raise, there is reason to believe the ...
Latest Updates on Ocata Therapeutics Inc (OTCMKTS:OCAT)  Equities Focus (registration)
Should You Purchase Ocata Therapeutics Inc(OCAT), Mitsubishi Estate Co Ltd ...  NIS
Related articles »  
Analyst Recommendation on Shares: Ocata Therapeutics Inc , Ocwen Financial ...
In the latest statement by the brokerage house, Maxim Group downgrades its outlook on Ocata Therapeutics Inc (NASDAQ:OCAT).
Related articles »  
Insider Transaction Update: Ocata Therapeutics, Inc. Chief Scientific Officer ...
Ocata Therapeutics, Inc. (NASDAQ:OCAT),The Chief Scientific Officer of Ocata Therapeutics Inc, Lanza Robert sold 8,930 shares at $12.53 on September 10, 2014.
Ocata Therapeutics Receives Two New Patents for Immune-modulatory Cell ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (�Ocata� or �the Company�; OTCBB: OCAT), a leader in the field of Regenerative OphthalmologyTM, today announced that the United States Patent and Trademark Office (USPTO) issued ...
2015 Brings Mixed Results For Ocata Therapeutics Inc (OTCMKTS:OCAT)  Traders350
Ocata Therapeutics, Inc. Files SEC Form SC 13G, Statement of Acquisition of ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S.
Should you place a bet on Ocata Therapeutics?
This brings us to Ocata Therapeutics. The company calls itself a "leader in regenerative medicine." What is that, and on what basis is Advanced Cell a leader in this field?
Related articles »  
Form SC 13G/A Ocata Therapeutics, Inc. Filed by: Aronson Gary D
Check the appropriate box to designate the Rule pursuant to which this Schedule is filed. �, Rule 13d-1(b). x, Rule 13d-1(c). �, Rule 13d-1(d).
Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc., (OTCBB:OCAT) today announced that it has been granted Advanced Therapy Medicinal Product (ATMP) designation for its RPE therapy for macular degeneration.
Related articles »